Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- initialism aviation
cockpit voice recorder
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word CVR.
Examples
-
The $80 figure includes a structure known as a contingent value right, or CVR, which is often used when buyers and sellers can't agree on a purchase price and usually kicks in after an acquired company meets sales or regulatory targets.
Sanofi, Genzyme Discuss New Deal Idea Gina Chon 2011
-
The terms include a contingent value right, or CVR, which is often used when buyers and sellers can't agree on a purchase price.
Sanofi Nears Genzyme Deal Gina Chon 2011
-
Helvea analyst Karl-Heinz Koch said a CVR was a smart way for Sanofi to deal with the unknowns surrounding Lemtrada.
Reuters: Top News 2011
-
The CVR is a tradable instrument, which promises a payout to shareholders over time, based on the performance of Genzyme's experimental drug Lemtrada for multiple sclerosis.
Reuters: Top News 2011
-
The CVR is a tradable instrument, which promises a payout to shareholders over time based on the performance of Genzyme's experimental drug Lemtrada for multiple sclerosis.
Reuters: Top News 2011
-
The CVR is a tradable instrument, which promises a payout to shareholders over time based on the performance of Genzyme's experimental drug Lemtrada for multiple sclerosis.
The Globe and Mail - Home RSS feed Toni Clarke 2011
-
The CVR is a tradable instrument, which promises a payout to shareholders over time based on the performance of Genzyme's experimental drug Lemtrada for multiple sclerosis.
Reuters: Top News 2011
-
Helvea analyst Karl-Heinz Koch said a CVR was a smart way for Sanofi to deal with the unknowns surrounding Lemtrada.
The Globe and Mail - Home RSS feed Toni Clarke 2011
-
The CVR is a tradable instrument, which promises a payout to shareholders over time based on the performance of Genzyme's experimental drug Lemtrada for multiple sclerosis.
Reuters: Top News 2011
-
Helvea analyst Karl-Heinz Koch said a CVR was a smart way for Sanofi to deal with the unknowns surrounding Lemtrada.
Reuters: Top News 2011
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.